Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1177

1.

Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study.

Hildick-Smith D, Landmesser U, Camm AJ, Diener HC, Paul V, Schmidt B, Settergren M, Teiger E, Nielsen-Kudsk JE, Tondo C.

Eur Heart J. 2020 Apr 3. pii: ehaa169. doi: 10.1093/eurheartj/ehaa169. [Epub ahead of print]

PMID:
32243499
2.

[Past and future of the ESUS concept].

Diener HC, Endres M.

Nervenarzt. 2020 Mar 27. doi: 10.1007/s00115-020-00893-1. [Epub ahead of print] Review. German.

PMID:
32221634
3.

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial.

Chabriat H, Bassetti CL, Marx U, Audoli-Inthavong ML, Sors A, Lambert E, Wattez M, Hermann DM; RESTORE BRAIN study investigators.

Lancet Neurol. 2020 Mar;19(3):226-233. doi: 10.1016/S1474-4422(20)30004-1.

PMID:
32085836
4.

Have the IHS Guidelines for controlled trials of acute treatment of migraine attacks been followed? Laying the ground for the 4th edition.

Alpuente A, Tassorelli C, Diener HC, Silberstein SD, Pozo-Rosich P.

Cephalalgia. 2020 Feb 14:333102420906843. doi: 10.1177/0333102420906843. [Epub ahead of print]

PMID:
32056459
5.

The Risks or Lack Thereof of Migraine Treatments in Vascular Disease.

Diener HC.

Headache. 2020 Mar;60(3):649-653. doi: 10.1111/head.13749. Epub 2020 Jan 22.

PMID:
31967337
6.

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.

Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Abraham A, Althaus K, Becks G, Berrouschot J, Berthel J, Bode FJ, Burghaus L, Cangür H, Daffertshofer M, Edelbusch S, Eggers J, Gerlach R, Gröschel K, Große-Dresselhaus F, Günther A, Haase CG, Haensch CA, Harloff A, Heckmann JG, Held V, Hieber M, Kauert A, Kern R, Kerz T, Köhrmann M, Kraft P, Kühnlein P, Latta J, Leinisch E, Lenz A, Leithner C, Neumann-Haefelin T, Mäurer M, Müllges W, Nolte CH, Obermann M, Partowi S, Patzschke P, Poli S, Pulkowski U, Purrucker J, Rehfeldt T, Ringleb PA, Röther J, Rossi R, El-Sabassy H, Sauer O, Schackert G, Schäfer N, Schellinger PD, Schneider A, Schuppner R, Schwab S, Schwarte O, Seitz RJ, Senger S, Shah YP, Sindern E, Sparenberg P, Steiner T, Szabo K, Urbanek C, Sarnowksi BV, Weissenborn K, Wienecke P, Witt K, Wruck R, Wunderlich S.

Int J Stroke. 2020 Jan 19:1747493019895654. doi: 10.1177/1747493019895654. [Epub ahead of print]

PMID:
31955706
7.

Results and lessons learnt from a randomized controlled trial: prophylactic treatment of vestibular migraine with metoprolol (PROVEMIG).

Bayer O, Adrion C, Al Tawil A, Mansmann U, Strupp M; PROVEMIG investigators.

Trials. 2019 Dec 30;20(1):813. doi: 10.1186/s13063-019-3903-5.

8.

The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.

Brandes JL, Diener HC, Dolezil D, Freeman MC, McAllister PJ, Winner P, Klatt J, Cheng S, Zhang F, Wen S, Ritter S, Lenz RA, Mikol DD.

Cephalalgia. 2020 Jan;40(1):28-38. doi: 10.1177/0333102419894559. Epub 2019 Dec 9.

PMID:
31816249
9.

Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program.

Mazurek M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Paquette M, Zint K, França LR, Lu S, Bartels DB, Huisman MV, Lip GYH; GLORIA-AF Investigators.

Am Heart J. 2019 Dec;218:123-127. doi: 10.1016/j.ahj.2019.08.012.

PMID:
31806087
10.

Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.

Paquette M, França LR, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL, Olshansky B, Huisman MV, Lip GYH, Nieuwlaat R.

Am J Cardiol. 2020 Feb 1;125(3):383-391. doi: 10.1016/j.amjcard.2019.10.047. Epub 2019 Nov 7.

11.

Viele Kinder plagen Kopfschmerzen.

Diener HC.

MMW Fortschr Med. 2019 Nov;161(20):35. doi: 10.1007/s15006-019-1114-3. Review. German. No abstract available.

PMID:
31773610
12.

Inaktivität gefährdet Herz und Hirn.

Diener HC.

MMW Fortschr Med. 2019 Nov;161(19):30. doi: 10.1007/s15006-019-1051-1. Review. German. No abstract available.

PMID:
31691229
13.

Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme.

Mazurek M, Halperin JL, Huisman MV, Diener HC, Dubner SJ, Ma CS, Rothman KJ, Healey JS, Teutsch C, Paquette M, França LR, Lu S, Bartels DB, Lip GYH.

Europace. 2020 Jan 1;22(1):47-57. doi: 10.1093/europace/euz278.

PMID:
31651951
14.
15.

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table.

Doehner W, Mazighi M, Hofmann BM, Lautsch D, Hindricks G, Bohula EA, Byrne RA, Camm AJ, Casadei B, Caso V, Cognard C, Diener HC, Endres M, Goldstein P, Halliday A, Hopewell JC, Jovanovic DR, Kobayashi A, Kostrubiec M, Krajina A, Landmesser U, Markus HS, Ntaios G, Pezzella FR, Ribo M, Rosano GM, Rubiera M, Sharma M, Touyz RM, Widimsky P.

Eur J Prev Cardiol. 2019 Sep 30:2047487319873460. doi: 10.1177/2047487319873460. [Epub ahead of print]

PMID:
31569966
16.

Problematic presentation and use of efficacy measures in current trials of CGRP monoclonal antibodies for episodic migraine prevention: A mini-review.

Tfelt-Hansen P, Diener HC, Steiner TJ.

Cephalalgia. 2020 Jan;40(1):122-126. doi: 10.1177/0333102419877663. Epub 2019 Sep 23.

PMID:
31547694
17.

Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: The multicentre, double-blind, randomised, sham-controlled PREMIUM trial.

Diener HC, Goadsby PJ, Ashina M, Al-Karagholi MA, Sinclair A, Mitsikostas D, Magis D, Pozo-Rosich P, Irimia Sieira P, Làinez MJ, Gaul C, Silver N, Hoffmann J, Marin J, Liebler E, Ferrari MD.

Cephalalgia. 2019 Oct;39(12):1475-1487. doi: 10.1177/0333102419876920. Epub 2019 Sep 15.

18.

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.

Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC; RE-SPECT CVT Study Group.

JAMA Neurol. 2019 Sep 3. doi: 10.1001/jamaneurol.2019.2764. [Epub ahead of print]

19.

[Optimal blood pressure control in patients with acute ischaemic stroke : ENCHANTED trial].

Diener HC, Nitschmann S.

Internist (Berl). 2019 Oct;60(10):1118-1120. doi: 10.1007/s00108-019-00659-1. German. No abstract available.

PMID:
31432198
20.

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial.

Ferrari MD, Diener HC, Ning X, Galic M, Cohen JM, Yang R, Mueller M, Ahn AH, Schwartz YC, Grozinski-Wolff M, Janka L, Ashina M.

Lancet. 2019 Sep 21;394(10203):1030-1040. doi: 10.1016/S0140-6736(19)31946-4. Epub 2019 Aug 16. Erratum in: Lancet. 2019 Oct 29;:.

PMID:
31427046
21.

Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.

Del Brutto VJ, Chaturvedi S, Diener HC, Romano JG, Sacco RL.

J Am Coll Cardiol. 2019 Aug 13;74(6):786-803. doi: 10.1016/j.jacc.2019.06.039. Review.

PMID:
31395130
22.

Implant for Augmentation of Cerebral Blood Flow Trial-1 (ImpACT-1). A single-arm feasibility study evaluating the safety and potential benefit of the Ischemic Stroke System for treatment of acute ischemic stroke.

Khurana D, Kaul S, Schneider D, Csanyi A, Adam I, Ichaporia NR, Griewing B, Csiba L, Valikovics A, Puri V, Diener HC, Schwab S, Hetzel A, Bornstein N; ImpACT-1 Study Group.

PLoS One. 2019 Jul 3;14(7):e0217472. doi: 10.1371/journal.pone.0217472. eCollection 2019.

23.

Antiplatelet Therapy After Noncardioembolic Stroke.

Greving JP, Diener HC, Reitsma JB, Bath PM, Csiba L, Hacke W, Kappelle LJ, Koudstaal PJ, Leys D, Mas JL, Sacco RL, Algra A.

Stroke. 2019 Jul;50(7):1812-1818. doi: 10.1161/STROKEAHA.118.024497. Epub 2019 Jun 10.

24.

Pathophysiology, prevention, and treatment of medication overuse headache.

Diener HC, Dodick D, Evers S, Holle D, Jensen RH, Lipton RB, Porreca F, Silberstein S, Schwedt T.

Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4. Review.

PMID:
31174999
25.

An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial.

Bornstein NM, Saver JL, Diener HC, Gorelick PB, Shuaib A, Solberg Y, Thackeray L, Savic M, Janelidze T, Zarqua N, Yarnitsky D, Molina CA; ImpACT-24B investigators.

Lancet. 2019 Jul 20;394(10194):219-229. doi: 10.1016/S0140-6736(19)31192-4. Epub 2019 May 24.

PMID:
31133406
26.

Sphenopalatine Ganglion Stimulation to Augment Cerebral Blood Flow.

Bornstein NM, Saver JL, Diener HC, Gorelick PB, Shuaib A, Solberg Y, Devlin T, Leung T, Molina CA; ImpACT-24A Investigators † ; ImpACT-24A Investigators include the Site Principal Investigators, DSMB members, and the Site Co-Investigators listed.

Stroke. 2019 May 23:STROKEAHA118024582. doi: 10.1161/STROKEAHA.118.024582. [Epub ahead of print]

PMID:
31117920
27.

Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data.

Dodick DW, Silberstein SD, Lipton RB, DeGryse RE, Adams AM, Diener HC.

Cephalalgia. 2019 Jul;39(8):945-956. doi: 10.1177/0333102418825382. Epub 2019 May 21.

PMID:
31112399
28.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
29.

Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults.

Deen M, Martinelli D, Pijpers J, Diener HC, Silberstein S, Ferrari MD, Ashina M, Tassorelli C, Yuan H.

Cephalalgia. 2019 Jul;39(8):1058-1066. doi: 10.1177/0333102419847751. Epub 2019 May 1.

PMID:
31042062
30.

Comment on: "Phytomedicines in the Treatment of Migraine".

Diener HC.

CNS Drugs. 2019 Jun;33(6):615. doi: 10.1007/s40263-019-00635-1. No abstract available.

PMID:
31041688
31.

[Heart and brain-two terms, one central problem : The stroke].

Erbel R, Diener HC.

Herz. 2019 Jun;44(4):287-288. doi: 10.1007/s00059-019-4810-y. German. No abstract available.

PMID:
31041491
32.

Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial.

Tepper SJ, Diener HC, Ashina M, Brandes JL, Friedman DI, Reuter U, Cheng S, Nilsen J, Leonardi DK, Lenz RA, Mikol DD.

Neurology. 2019 May 14;92(20):e2309-e2320. doi: 10.1212/WNL.0000000000007497. Epub 2019 Apr 17.

33.

DOAK nach der Klinik verhindern keine VTE.

Diener HC.

MMW Fortschr Med. 2019 Apr;161(7):34. doi: 10.1007/s15006-019-0402-2. Review. German. No abstract available.

PMID:
30989524
34.

Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.

Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbüchel H, Mont L, Morillo CA, Abozguia K, Grimaldi M, Rauer H, Reimitz PE, Smolnik R, Mönninghoff C, Kautzner J.

Eur Heart J. 2019 Sep 21;40(36):3013-3021. doi: 10.1093/eurheartj/ehz190. Erratum in: Eur Heart J. 2019 Sep 21;40(36):3043.

35.

Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.

Abu-Arafeh I, Hershey AD, Diener HC, Tassorelli C; Clinical Trials Standing Committee and the Child and Adolescent Standing Committee of the International Headache Society.

Cephalalgia. 2019 Jun;39(7):803-816. doi: 10.1177/0333102419842188. Epub 2019 Apr 4.

PMID:
30947525
36.

[Closure of the patent foramen ovale (PFO) in cryptogenic stroke].

Diener HC, Knebel F.

Herz. 2019 Jun;44(4):304-309. doi: 10.1007/s00059-019-4800-0. German.

PMID:
30941472
37.

[Headache - an Update 2018].

Diener HC, Gaul C, Holle-Lee D, Jürgens TP, Kraya T, Kurth T, Nägel S, Neeb L, Straube A.

Laryngorhinootologie. 2019 Mar;98(3):192-217. doi: 10.1055/a-0823-4814. Epub 2019 Mar 7. German.

PMID:
30847888
38.

Rationale and design for AMPLATZER Amulet Left Atrial Appendage Occluder IDE randomized controlled trial (Amulet IDE Trial).

Lakkireddy D, Windecker S, Thaler D, Søndergaard L, Carroll J, Gold MR, Guo H, Brunner KJ, Hermiller JB, Diener HC, Schmidt B, MacDonald L, Mansour M, Maini B, Levine J.

Am Heart J. 2019 May;211:45-53. doi: 10.1016/j.ahj.2018.12.010. Epub 2018 Dec 21.

PMID:
30831333
39.

Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J; International Headache Society Clinical Trials Standing Committee.

Cephalalgia. 2019 May;39(6):687-710. doi: 10.1177/0333102419828967. Epub 2019 Feb 26.

40.

Glucose Modifies the Effect of Endovascular Thrombectomy in Patients With Acute Stroke.

Chamorro Á, Brown S, Amaro S, Hill MD, Muir KW, Dippel DWJ, van Zwam W, Butcher K, Ford GA, den Hertog HM, Mitchell PJ, Demchuk AM, Majoie CBLM, Bracard S, Sibon I, Jadhav AP, Lara-Rodriguez B, van der Lugt A, Osei E, Renú A, Richard S, Rodriguez-Luna D, Donnan GA, Dixit A, Almekhlafi M, Deltour S, Epstein J, Guillon B, Bakchine S, Gomis M, du Mesnil de Rochemont R, Lopes D, Reddy V, Rudel G, Roos YBWEM, Bonafe A, Diener HC, Berkhemer OA, Cloud GC, Davis SM, van Oostenbrugge R, Guillemin F, Goyal M, Campbell BCV, Menon BK; HERMES Collaborators.

Stroke. 2019 Mar;50(3):690-696. doi: 10.1161/STROKEAHA.118.023769.

PMID:
30777000
41.

Stroke aetiological classification reliability and effect on trial sample size: systematic review, meta-analysis and statistical modelling.

Abdul-Rahim AH, Dickie DA, Selvarajah JR, Lees KR, Quinn TJ; VISTA Collaborators.

Trials. 2019 Feb 8;20(1):107. doi: 10.1186/s13063-019-3222-x.

42.

Atrial Fibrillation and Cognitive Function: JACC Review Topic of the Week.

Diener HC, Hart RG, Koudstaal PJ, Lane DA, Lip GYH.

J Am Coll Cardiol. 2019 Feb 12;73(5):612-619. doi: 10.1016/j.jacc.2018.10.077. Review.

43.

CGRP antibodies for migraine prevention - new kids on the block.

Diener HC.

Nat Rev Neurol. 2019 Mar;15(3):129-130. doi: 10.1038/s41582-019-0139-7. No abstract available.

PMID:
30710130
44.

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.

De Caterina R, Ageno W, Agnelli G, Chan NC, Diener HC, Hylek E, Raskob GE, Siegal DM, Verheugt FWA, Lip GYH, Weitz JI.

Thromb Haemost. 2019 Jan;119(1):14-38. doi: 10.1055/s-0038-1675816. Epub 2018 Dec 31. Review.

PMID:
30597497
45.

Real-world comparison of in-hospital Reveal LINQ insertable cardiac monitor insertion inside and outside of the cardiac catheterization or electrophysiology laboratory.

Beinart SC, Natale A, Verma A, Amin A, Kasner S, Diener HC, Del Greco M, Wilkoff BL, Pouliot E, Franco N, Mittal S.

Am Heart J. 2019 Jan;207:76-82. doi: 10.1016/j.ahj.2018.10.002. Epub 2018 Oct 14.

PMID:
30487072
46.

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed.

Martelletti P, Schwedt TJ, Lanteri-Minet M, Quintana R, Carboni V, Diener HC, Ruiz de la Torre E, Craven A, Rasmussen AV, Evans S, Laflamme AK, Fink R, Walsh D, Dumas P, Vo P.

J Headache Pain. 2018 Nov 27;19(1):115. doi: 10.1186/s10194-018-0946-z.

47.

Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data.

Campbell BCV, Majoie CBLM, Albers GW, Menon BK, Yassi N, Sharma G, van Zwam WH, van Oostenbrugge RJ, Demchuk AM, Guillemin F, White P, Dávalos A, van der Lugt A, Butcher KS, Cherifi A, Marquering HA, Cloud G, Macho Fernández JM, Madigan J, Oppenheim C, Donnan GA, Roos YBWEM, Shankar J, Lingsma H, Bonafé A, Raoult H, Hernández-Pérez M, Bharatha A, Jahan R, Jansen O, Richard S, Levy EI, Berkhemer OA, Soudant M, Aja L, Davis SM, Krings T, Tisserand M, San Román L, Tomasello A, Beumer D, Brown S, Liebeskind DS, Bracard S, Muir KW, Dippel DWJ, Goyal M, Saver JL, Jovin TG, Hill MD, Mitchell PJ; HERMES collaborators.

Lancet Neurol. 2019 Jan;18(1):46-55. doi: 10.1016/S1474-4422(18)30314-4. Epub 2018 Nov 6. Erratum in: Lancet Neurol. 2019 Mar;18(3):e2.

PMID:
30413385
48.

In Reply.

Diener HC.

Dtsch Arztebl Int. 2018 Sep 21;115(38):638. doi: 10.3238/arztebl.2018.0638b. No abstract available.

49.

Polarity-specific modulation of pain processing by transcranial direct current stimulation - a blinded longitudinal fMRI study.

Naegel S, Biermann J, Theysohn N, Kleinschnitz C, Diener HC, Katsarava Z, Obermann M, Holle D.

J Headache Pain. 2018 Oct 24;19(1):99. doi: 10.1186/s10194-018-0924-5.

50.

Chronischer Schmerz: Opioide ohne Vorteil.

Diener HC.

MMW Fortschr Med. 2018 Oct;160(18):38. doi: 10.1007/s15006-018-1022-y. Review. German. No abstract available.

PMID:
30350070

Supplemental Content

Loading ...
Support Center